A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Objectives Our aim was to investigate the safety and efficacy of intravenous allogeneic human mesenchymal stem cells (hMSCs) in patients with myocardial infarction (MI). Background Bone marrow-derived hMSCs may ameliorate consequences of MI, and have the advantages of preparation ease, allogeneic use due to immunoprivilege, capacity to home to injured tissue, and extensive pre-clinical support. Methods We performed a double-blind, placebo-controlled, dose-ranging (0.5, 1.6, and 5 million cells/kg) safety trial of intravenous allogeneic hMSCs (Prochymal, Osiris Therapeutics, Inc., Baltimore, Maryland) in reperfused MI patients (n = 53). The primary end point was incidence of treatment-emergent adverse events within 6 months. Ejection fraction and left ventricular volumes determined by echocardiography and magnetic resonance imaging were exploratory efficacy end points. Results Adverse event rates were similar between the hMSC-treated (5.3 per patient) and placebo-treated (7.0 per patient) groups, and renal, hepatic, and hematologic laboratory indexes were not different. Ambulatory electrocardiogram monitoring demonstrated reduced ventricular tachycardia episodes (p = 0.025), and pulmonary function testing demonstrated improved forced expiratory volume in 1 s (p = 0.003) in the hMSC-treated patients. Global symptom score in all patients (p = 0.027) and ejection fraction in the important subset of anterior MI patients were both significantly better in hMSCs versus placebo subjects. In the cardiac magnetic resonance imaging substudy, hMSC treatment, but not placebo, increased left ventricular ejection fraction and led to reverse remodeling. Conclusions Intravenous allogeneic hMSCs are safe in patients after acute MI. This trial provides pivotal safety and provisional efficacy data for an allogeneic bone marrow-derived stem cell in post-infarction patients. (Safety Study of Adult Mesenchymal Stem Cells [MSC] to Treat Acute Myocardial Infarction; NCT00114452)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Spontaneous Human Adult Stem Cell Transformation
Rubio, D., Garcia-Castro, J., Martín, M. C., de la Fuente, R., Cigudosa, J. C., Lloyd, A. C., & Bernad, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4194 · Cited by 1,036
RetractedMiller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Self-citationThe Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,188
Chamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,381
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060186 · Cited by 1,890
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Reference spirometric values using techniques and equipment that meet ATS recommendations.
Terrin, M. (1981) · PubMed · doi:10.1164/arrd.1981.124.6.763c · Cited by 1,374
The Thrombolysis in Myocardial Infarction (TIMI) Trial
(1985) · New England Journal of Medicine · doi:10.1056/nejm198510173131611 · Cited by 1,319
Cited by
Stem Cell Therapies in Clinical Trials: Progress and Challenges
Trounson, A., & McDonald, C. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.007 · Cited by 1,468
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Murphy, M. B., Moncivais, K., & Caplan, A. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.94 · Cited by 1,231
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0023-5 · Cited by 1,223
Laflamme, M. A., & Murry, C. E. (2011) · Nature · doi:10.1038/nature10147 · Cited by 1,206
Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.25321 · Cited by 1,192
Self-citationLalu, M. M., McIntyre, L., Pugliese, C., Fergusson, D., Winston, B. W., Marshall, J. C., Granton, J., Stewart, D. J., & Canadian Critical Care Trials Group (2012) · PLoS ONE · doi:10.1371/journal.pone.0047559 · Cited by 1,146
Williams, A. R., & Hare, J. M. (2011) · Circulation Research · doi:10.1161/circresaha.111.243147 · Cited by 886
Self-citationEthical and Safety Issues of Stem Cell-Based Therapy
Volarevic, V., Markovic, B. S., Gazdic, M., Volarevic, A., Jovicic, N., Arsenijevic, N., Armstrong, L., Djonov, V., Lako, M., & Stojkovic, M. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.21666 · Cited by 876
Emerging trends and new developments in regenerative medicine: a scientometric update (2000 – 2014)
Chen, C., Dubin, R., & Kim, M. C. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.920813 · Cited by 837
Strioga, M., Viswanathan, S., Darinskas, A., Slaby, O., & Michalek, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0722 · Cited by 825
Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease
Ranganath, S. H., Levy, O., Inamdar, M. S., & Karp, J. M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.005 · Cited by 809
Eggenhofer, E., Benseler, V., Kroemer, A., Popp, F. C., Geissler, E. K., Schlitt, H. J., Baan, C. C., Dahlke, M. H., & Hoogduijn, M. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00297 · Cited by 804
“ORIGINAL RESEARCH ARTICLE published: 26 September 2012 doi: 10.3389/fimmu.2012.00297 Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion”
BackgroundMethodInfluentialMesenchymal stromal cells: new directions
Keating, A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.015 · Cited by 778
Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy
Kourembanas, S. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071641 · Cited by 761
Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery
Yeo, R. W. Y., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.001 · Cited by 746
Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation
Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., Hu, Q., Feigenbaum, G. S., Margitich, I. S., Mazhari, R., Boyle, A. J., Zambrano, J. P., Rodriguez, J. E., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.222703 · Cited by 715
Self-citationMesenchymal stem cell therapy: Two steps forward, one step back
Ankrum, J., & Karp, J. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.02.005 · Cited by 614
Heldman, A. W., DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., et al. (2014) · JAMA · doi:10.1001/jama.2013.282909 · Cited by 570
Self-citationMesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
Lai, R. C., Chen, T. S., & Lim, S. K. (2011) · Regenerative Medicine · doi:10.2217/rme.11.35 · Cited by 553
Exosomes for drug delivery—A novel application for the mesenchymal stem cell
Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.008 · Cited by 546
Mesenchymal stem cells for the treatment of neurodegenerative disease
Joyce, N., Annett, G., Wirthlin, L., Olson, S., Bauer, G., & Nolta, J. A. (2010) · Regenerative Medicine · doi:10.2217/rme.10.72 · Cited by 501
Intracoronary Cardiosphere-Derived Cells After Myocardial Infarction
Malliaras, K., Makkar, R. R., Smith, R. R., Cheng, K., Wu, E., Bonow, R. O., Marbán, L., Mendizabal, A., Cingolani, E., Johnston, P. V., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.724 · Cited by 495
Self-citationCardiopoietic Stem Cell Therapy in Heart Failure
Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.071 · Cited by 493
Bartolucci, J., Verdugo, F. J., González, P. L., Larrea, R. E., Abarzua, E., Goset, C., Rojo, P., Palma, I., Lamich, R., Pedreros, P. A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310712 · Cited by 487
Lu, D., Chen, B., Liang, Z., Deng, W., Jiang, Y., Li, S., Xu, J., Wu, Q., Zhang, Z., Xie, B., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.12.010 · Cited by 468
Li, T.-S., Cheng, K., Malliaras, K., Smith, R. R., Zhang, Y., Sun, B., Matsushita, N., Blusztajn, A., Terrovitis, J., Kusuoka, H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.029 · Cited by 461
Konala, V. B. R., Mamidi, M. K., Bhonde, R., Das, A. K., Pochampally, R., & Pal, R. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2015.10.008 · Cited by 451
Mazini, L., Rochette, L., Amine, M., & Malka, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102523 · Cited by 445
Stem cell treatment for acute myocardial infarction
Fisher, S. A., Zhang, H., Doree, C., Mathur, A., & Martin-Rendon, E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006536.pub4 · Cited by 445
Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices
Sharma, R. R., Pollock, K., Hubel, A., & McKenna, D. (2014) · Transfusion · doi:10.1111/trf.12421 · Cited by 430
Zheng, G., Huang, L., Tong, H., Shu, Q., Hu, Y., Ge, M., Deng, K., Zhang, L., Zou, B., Cheng, B., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-39 · Cited by 428
Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease
Karantalis, V., & Hare, J. M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303614 · Cited by 425
Self-citationA Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD
Weiss, D. J., Casaburi, R., Flannery, R., LeRoux-Williams, M., & Tashkin, D. P. (2013) · Chest · doi:10.1378/chest.12-2094 · Cited by 423
Wang, X., Chen, Y., Zhao, Z., Meng, Q., Yu, Y., Sun, J., Yang, Z., Chen, Y., Li, J., Ma, T., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008737 · Cited by 422
Jeong, J.-O., Han, J. W., Kim, J.-M., Cho, H.-J., Park, C., Lee, N., Kim, D.-W., & Yoon, Y.-S. (2011) · Circulation Research · doi:10.1161/circresaha.110.239848 · Cited by 410
Vangsness, C. T., Farr, J., Boyd, J., Dellaero, D. T., Mills, C. R., & LeRoux-Williams, M. (2014) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.m.00058 · Cited by 409
Traverse, J. H. (2011) · JAMA · doi:10.1001/jama.2011.1670 · Cited by 405
Self-citationTraverse, J. H., Henry, T. D., Pepine, C. J., Willerson, J. T., Zhao, D. X. M., Ellis, S. G., Forder, J. R., Anderson, R. D., Hatzopoulos, A. K., Penn, M. S., et al. (2012) · JAMA · doi:10.1001/jama.2012.28726 · Cited by 392
Self-citationLoffredo, F. S., Steinhauser, M. L., Gannon, J., & Lee, R. T. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.02.002 · Cited by 385
Huang, X.-P., Sun, Z., Miyagi, Y., McDonald Kinkaid, H., Zhang, L., Weisel, R. D., & Li, R.-K. (2010) · Circulation · doi:10.1161/circulationaha.110.955971 · Cited by 373
Hare, J. M., DiFede, D. L., Rieger, A. C., Florea, V., Landin, A. M., El-Khorazaty, J., Khan, A., Mushtaq, M., Lowery, M. H., Byrnes, J. J., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.009 · Cited by 355
Self-citationBronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., & Lambrichts, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.013 · Cited by 354
Karantalis, V., DiFede, D. L., Gerstenblith, G., Pham, S., Symes, J., Zambrano, J. P., Fishman, J., Pattany, P., McNiece, I., Conte, J., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.303180 · Cited by 348
Self-citationGolpanian, S., Wolf, A., Hatzistergos, K. E., & Hare, J. M. (2016) · Physiological Reviews · doi:10.1152/physrev.00019.2015 · Cited by 343
Self-citationImmunogenicity of allogeneic mesenchymal stem cells
Schu, S., Nosov, M., O'Flynn, L., Shaw, G., Treacy, O., Barry, F., Murphy, M., O'Brien, T., & Ritter, T. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01509.x · Cited by 324
Clinical applications of mesenchymal stem cells
Kim, N., & Cho, S.-G. (2013) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2013.28.4.387 · Cited by 314
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Kolls, J. K., Ortiz, L. A., Panoskaltsis-Mortari, A., & Prockop, D. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200804-037dw · Cited by 309
Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues
Ren, G., Chen, X., Dong, F., Li, W., Ren, X., Zhang, Y., & Shi, Y. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0019 · Cited by 307
Schultheiss, H.-P., Kuhl, U., & Cooper, L. T. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr165 · Cited by 301
Shao, L., Zhang, Y., Lan, B., Wang, J., Zhang, Z., Zhang, L., Xiao, P., Meng, Q., Geng, Y.-J., Yu, X.-Y., et al. (2017) · BioMed Research International · doi:10.1155/2017/4150705 · Cited by 300
Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review
Nguyen, P. K., Rhee, J.-W., & Wu, J. C. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2225 · Cited by 299
The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
Guo, Y., Yu, Y., Hu, S., Chen, Y., & Shen, Z. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2542-9 · Cited by 298
The Translation of Cell-Based Therapies: Clinical Landscape and Manufacturing Challenges
Heathman, T. R., Nienow, A. W., McCall, M. J., Coopman, K., Kara, B., & Hewitt, C. J. (2015) · Regenerative Medicine · doi:10.2217/rme.14.73 · Cited by 297
Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment
Yaghoubi, Y., Movassaghpour, A., Zamani, M., Talebi, M., Mehdizadeh, A., & Yousefi, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116733 · Cited by 294
Chen, A. K.-L., Reuveny, S., & Oh, S. K. W. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.006 · Cited by 292
Collagen Promotes Higher Adhesion, Survival and Proliferation of Mesenchymal Stem Cells
Somaiah, C., Kumar, A., Mawrie, D., Sharma, A., Patil, S. D., Bhattacharyya, J., Swaminathan, R., & Jaganathan, B. G. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145068 · Cited by 290
Qiu, G., Zheng, G., Ge, M., Wang, J., Huang, R., Shu, Q., & Xu, J. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1069-9 · Cited by 289
Thompson, M., Mei, S. H. J., Wolfe, D., Champagne, J., Fergusson, D., Stewart, D. J., Sullivan, K. J., Doxtator, E., Lalu, M., English, S. W., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.100249 · Cited by 283
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial
Perin, E. C., Sanz-Ruiz, R., Sánchez, P. L., Lasso, J., Pérez-Cano, R., Alonso-Farto, J. C., Pérez-David, E., Fernández-Santos, M. E., Serruys, P. W., Duckers, H. J., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.03.022 · Cited by 283
Advancing application of mesenchymal stem cell-based bone tissue regeneration
Shang, F., Yu, Y., Liu, S., Ming, L., Zhang, Y., Zhou, Z., Zhao, J., & Jin, Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.08.014 · Cited by 280
Stem cells as drug delivery methods: Application of stem cell secretome for regeneration
Tran, C., & Damaser, M. S. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.007 · Cited by 278
Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
Tao, H., Han, Z., Han, Z. C., & Li, Z. (2016) · Stem Cells International · doi:10.1155/2016/1314709 · Cited by 276
Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21
Wang, K., Jiang, Z., Webster, K. A., Chen, J., Hu, H., Zhou, Y., Zhao, J., Wang, L., Wang, Y., Zhong, Z., et al. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0386 · Cited by 274
The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential
Watt, S. M., Gullo, F., van der Garde, M., Markeson, D., Camicia, R., Khoo, C. P., & Zwaginga, J. J. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt031 · Cited by 273
Behfar, A., Yamada, S., Crespo-Diaz, R., Nesbitt, J. J., Rowe, L. A., Perez-Terzic, C., Gaussin, V., Homsy, C., Bartunek, J., & Terzic, A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.066 · Cited by 270
Wang, D., Zhang, H., Liang, J., Li, X., Feng, X., Wang, H., Hua, B., Liu, B., Lu, L., Gilkeson, G. S., et al. (2013) · Cell Transplantation · doi:10.3727/096368911x582769c · Cited by 268
Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
Volarevic, V., Arsenijevic, N., Lukic, M. L., & Stojkovic, M. (2011) · Stem Cells · doi:10.1002/stem.556 · Cited by 265
Macrophage Subpopulations Are Essential for Infarct Repair With and Without Stem Cell Therapy
Ben-Mordechai, T., Holbova, R., Landa-Rouben, N., Harel-Adar, T., Feinberg, M. S., Abd Elrahman, I., Blum, G., Epstein, F. H., Silman, Z., Cohen, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.057 · Cited by 263
Zhao, Y., Sun, X., Cao, W., Ma, J., Sun, L., Qian, H., Zhu, W., & Xu, W. (2015) · Stem Cells International · doi:10.1155/2015/761643 · Cited by 257
Tzouvelekis, A., Paspaliaris, V., Koliakos, G., Ntolios, P., Bouros, E., Oikonomou, A., Zissimopoulos, A., Boussios, N., Dardzinski, B., Gritzalis, D., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-171 · Cited by 255
“The latter studies offered pivotal clinical insights and accidentally in one of them authors came up with an exploratory finding as they reported lung function improvement in the majority of patients [40].”
BackgroundResultInfluentialPostischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications
Silvestre, J.-S., Smadja, D. M., & Lévy, B. I. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2013 · Cited by 255
Glassberg, M. K., Minkiewicz, J., Toonkel, R. L., Simonet, E. S., Rubio, G. A., DiFede, D., Shafazand, S., Khan, A., Pujol, M. V., LaRussa, V. F., et al. (2017) · Chest · doi:10.1016/j.chest.2016.10.061 · Cited by 249
“An alternative approach could be to dose patients by body weight as in previous hMSC trials.(16-20,23)”
BackgroundMethodInfluentialSelf-citationTongers, J., Losordo, D. W., & Landmesser, U. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr018 · Cited by 244
Strzelec, M., Detka, J., Mieszczak, P., Sobocińska, M. K., & Majka, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127704 · Cited by 233
Park, S.-J., Kim, R. Y., Park, B.-W., Lee, S., Choi, S. W., Park, J.-H., Choi, J. J., Kim, S.-W., Jang, J., Cho, D.-W., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11091-2 · Cited by 219
Biomaterial strategies for alleviation of myocardial infarction
Venugopal, J. R., Prabhakaran, M. P., Mukherjee, S., Ravichandran, R., Dan, K., & Ramakrishna, S. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0301 · Cited by 211
Drug and cell delivery for cardiac regeneration
Hastings, C. L., Roche, E. T., Ruiz-Hernandez, E., Schenke-Layland, K., Walsh, C. J., & Duffy, G. P. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.006 · Cited by 200
Dmitrieva, R. I., Minullina, I. R., Bilibina, A. A., Tarasova, O. V., Anisimov, S. V., & Zaritskey, A. Y. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18858 · Cited by 195
Mesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potential
Volarevic, V., Gazdic, M., Simovic Markovic, B., Jovicic, N., Djonov, V., & Arsenijevic, N. (2017) · BioFactors · doi:10.1002/biof.1374 · Cited by 195
“In a phase I clinical study [95], 53 patients were randomized to receive either allogeneic MSCs or placebo, 7 to 10 days after myocardial infarction.”
BackgroundButler, J., Epstein, S. E., Greene, S. J., Quyyumi, A. A., Sikora, S., Kim, R. J., Anderson, A. S., Wilcox, J. E., Tankovich, N. I., Lipinski, M. J., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309717 · Cited by 179
Luger, D., Lipinski, M. J., Westman, P. C., Glover, D. K., Dimastromatteo, J., Frias, J. C., Albelda, M. T., Sikora, S., Kharazi, A., Vertelov, G., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310599 · Cited by 173
Cardiac cell therapy: Lessons from clinical trials
Menasche, P. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.06.010 · Cited by 172
“For thosewith acute infarctions in whom the intracoronary route is the only available, MSC have raise safety concerns related to their size although this problem seems to be addressed by an appropriate cell dosing and a bracketing of the procedure by a robust anti-thrombotic therapy [43].”
BackgroundResultInfluentialTompkins, B. A., DiFede, D. L., Khan, A., Landin, A. M., Schulman, I. H., Pujol, M. V., Heldman, A. W., Miki, R., Goldschmidt-Clermont, P. J., Goldstein, B. J., et al. (2017) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx137 · Cited by 169
“Given the novel use of MSCs in frailty, a patient population for whom a successful therapy has yet to be developed, dosing was based on safety as established by previous studies (18,19) and phase I (17), and was further investigated in the current study.”
MethodSelf-citationBeitnes, J. O., Hopp, E., Lunde, K., Solheim, S., Arnesen, H., Brinchmann, J. E., Forfang, K., & Aakhus, S. (2009) · Heart · doi:10.1136/hrt.2009.178913 · Cited by 169
Stem cell therapies for wound healing
Kosaric, N., Kiwanuka, H., & Gurtner, G. C. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1596257 · Cited by 168
“the lung, resulting in few cells reaching their target site [83].”
BackgroundWharton’s Jelly stem cells: Future clinical applications
Taghizadeh, R. R., Cetrulo, K. J., & Cetrulo, C. L. (2011) · Placenta · doi:10.1016/j.placenta.2011.06.010 · Cited by 166
Alcayaga-Miranda, F., Cuenca, J., Martin, A., Contreras, L., Figueroa, F. E., & Khoury, M. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0192-0 · Cited by 165
“farction [42, 43], and sepsis [3, 5].”
Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia
Liew, A., & O'Brien, T. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt119 · Cited by 161
Wysoczynki, M., Khan, A., & Bolli, R. (2018) · Circulation Research · doi:10.1161/circresaha.118.313251 · Cited by 161
“25,104,110–112 In addition, the secretome of cardiosphere-derived cells (CDCs) polarizes macrophages to a phenotype distinct from that of classically or alternatively polarized macrophages, enhances their phagocytosis, and decreases expression of CD80 and CD86, 2 obligatory T cell costimulatory receptors.113 Data are…”
BackgroundInfluentialGenetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy
Hodgkinson, C. P., Gomez, J. A., Mirotsou, M., & Dzau, V. J. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.165 · Cited by 150
Mesenchymal stem cell transplantation in multiple sclerosis
Cohen, J. A. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.12.009 · Cited by 127
Cai, B., Ma, W., Bi, C., Yang, F., Zhang, L., Han, Z., Huang, Q., Ding, F., Li, Y., Yan, G., et al. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12331 · Cited by 98
Song, Y.-S., Joo, H.-W., Park, I.-H., Shen, G.-Y., Lee, Y., Shin, J. H., Kim, H., & Kim, K.-S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179972 · Cited by 53
Amadeo, F., Trivino Cepeda, K., Littlewood, J., Wilm, B., Taylor, A., & Murray, P. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20210013 · Cited by 20
Wiren, K. M., Hashimoto, J. G., & Zhang, X.-W. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23288 · Cited by 5
Metadata
- Authors
- Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., Hermiller, J. B., Reisman, M. A., Schaer, G. L., & Sherman, W.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 54
- Issue
- 24
- Pages
- 2277-2286
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2003996125
- Cited by
- 1,350
- References
- 37
- FWCI
- 56.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.